Skip to main content
SpringerLink
Log in

Screening, epidemiology, molecular biology, and treatment strategies for endometriosis-associated ovarian cancer

  • Review Article
  • Published:
Reproductive Medicine and Biology

Abstract

Objectives

This article reviews recent data on the biology, pathogenesis and pathophysiology of the different entity of epithelial ovarian cancer (EOC).

Study design

The present article reviews the English language literature for screening, epidemiology, clinical diagnosis, natural history, preclinical and clinical trials, and promising molecular targets on EOC, particularly for clear cell EOC (cEOC) based on the gene expression profiling studies.

Results

Prospective ovarian cancer screening trials in Japan showed that (1) serous-type EOC (sEOC) may exhibit a rapid progression possibly through de novo carcinogenesis, (2) the EOC risk was elevated significantly among patients with ovarian endometrioma (SIR = 8.95), (3) advancing age (>40 years) and the diameter of endometriomas (>9 cm) were independent predictors of development of EOC, (4) the benign-appearing ovarian masses are present several years before the EOC diagnosis in patients with endometriosis-associated EOC, and (5) the slightly elevated CA125 level is also typically present many years (>3 years) before the diagnosis in these patients. Upregulation of HNF-1beta and PLK-Emi1 genes were specifically detected in cEOC. In addition, the therapy currently used in renal cell carcinoma (RCC) should be considered as an attractive therapeutic option for cEOC.

Conclusions

Ovarian endometrioma could be viewed as a neoplastic process, particularly in perimenopausal women. Understanding the mechanisms of endometriosis development and elucidating its pathogenesis and pathophysiology are intrinsic to prevention and the search for effective therapies of endometriosis-associated EOC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Permuth-Wey J, Sellers TA. Epidemiology of ovarian cancer. Methods Mol Biol. 2009;472:413–37.

    Article  PubMed  Google Scholar 

  2. Kobayashi H, Yamada Y, Sado T, et al. A randomized study of screening for ovarian cancer: a multicenter study in Japan. Int J Gynecol Cancer. 2008;18(3):414–20.

    Article  CAS  PubMed  Google Scholar 

  3. Menon U, Gentry-Maharaj A, Hallett R, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009;10(4):327–40.

    Article  PubMed  Google Scholar 

  4. Pectasides D, Pectasides E, Psyrri A, et al. Treatment issues in clear cell carcinoma of the ovary: a different entity? Oncologist. 2006;11:1089–94.

    Article  PubMed  Google Scholar 

  5. Adley BP, Gleason KJ, Yang XJ, et al. Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: High level expression in clear cell carcinoma. Gynecol Oncol. 2009 (in press).

  6. Sugiyama T, Kamura T, Kigawa J, et al. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer. 2000;88:2584–9.

    Article  CAS  PubMed  Google Scholar 

  7. Nakazato T, Kanuma T, Tamura T, et al. Sperm protein 17 influences the tissue-specific malignancy of clear cell adenocarcinoma in human epithelial ovarian cancer. Int J Gynecol Cancer. 2007;17:426–32.

    Article  CAS  PubMed  Google Scholar 

  8. Itamochi H, Kigawa J. Incidence of ovarian cancer in Japan. Obstet Gynecol (Tokyo). 2005;5:545–9. (in Japanese).

    Google Scholar 

  9. Olive DL. Medical therapy of endometriosis. Semin Reprod Med. 2003;21:209–22.

    Article  CAS  PubMed  Google Scholar 

  10. Brinton LA, Gridley G, Persson I, et al. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol. 1997;176:572–9.

    Article  CAS  PubMed  Google Scholar 

  11. Ness RB, Cramer DW, Goodman MT, et al. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case–control studies. Am J Epidemiol. 2002;155:217–24.

    Article  PubMed  Google Scholar 

  12. Brinton LA, Lamb EJ, Moghissi KS, et al. Ovarian cancer risk associated with varying causes of infertility. Fertil Steril. 2004;82:405–14.

    Article  PubMed  Google Scholar 

  13. Borgfeldt C, Andolf E. Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis. Acta Obstet Gynecol Scand. 2004;83:395–400.

    PubMed  Google Scholar 

  14. Jimbo H, Yoshikawa H, Onda T, et al. Prevalence of ovarian endometriosis in epithelial ovarian cancer. Int J Gynaecol Obstet. 1997;59:245–50.

    Article  CAS  PubMed  Google Scholar 

  15. Komiyama S, Aoki D, Tominaga E, et al. Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathologic evaluation. Gynecol Oncol. 1999;72:342–6.

    Article  CAS  PubMed  Google Scholar 

  16. Yoshikawa H, Jimbo H, Okada S, et al. Prevalence of endometriosis in ovarian cancer. Gynecol Obstet Invest. 2000;50(Suppl 1):11–7.

    Article  PubMed  Google Scholar 

  17. Nishida M, Watanabe K, Sato N, et al. Malignant transformation of ovarian endometriosis. Gynecol Obstet Invest. 2000;50(Suppl 1):18–25.

    Article  PubMed  Google Scholar 

  18. Okugawa K, Hirakawa T, Fukushima K, et al. Relationship between age, histological type, and size of ovarian tumors. Int J Gynaecol Obstet. 2001;74:45–50.

    Article  CAS  PubMed  Google Scholar 

  19. Ness RB. Endometriosis and ovarian cancer: thoughts on shared pathophysiology. Am J Obstet Gynecol. 2003;189:280–94.

    Article  PubMed  Google Scholar 

  20. Kobayashi H, Sumimoto K, Moniwa N, et al. Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan. Int J Gynecol Cancer. 2007;17:37–43.

    Article  CAS  PubMed  Google Scholar 

  21. Kobayashi H, Sumimoto K, Kitanaka T, et al. Ovarian endometrioma—risks factors of ovarian cancer development. Eur J Obstet Gynecol Reprod Biol. 2008;138(2):187–93.

    Article  PubMed  Google Scholar 

  22. Takano M, Kikuchi Y, Yaegashi N, et al. Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging. Br J Cancer. 2006;94:1369–74.

    Article  CAS  PubMed  Google Scholar 

  23. Schwartz DR, Kardia SL, Shedden KA, et al. Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer Res. 2002;62:4722–9.

    CAS  PubMed  Google Scholar 

  24. Kita T, Kikuchi Y, Kudoh K, et al. Exploratory study of effective chemotherapy to clear cell carcinoma of the ovary. Oncol Rep. 2000;7:327–31.

    CAS  PubMed  Google Scholar 

  25. Pather S, Quinn MA. Clear-cell cancer of the ovary-is it chemosensitive? Int J Gynecol Cancer. 2005;15:432–7.

    Article  CAS  PubMed  Google Scholar 

  26. Goff BA, Sainz de la Cuesta R, Muntz HG, et al. Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol Oncol. 1996;60:412–7.

    Article  CAS  PubMed  Google Scholar 

  27. Recio FO, Piver MS, Hempling RE, et al. Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy. Cancer. 1996;78:2157–63.

    Article  CAS  PubMed  Google Scholar 

  28. Gorai I, Nakazawa T, Miyagi E, et al. Establishment and characterization of two human ovarian clear cell adenocarcinoma lines from metastatic lesions with different properties. Gynecol Oncol. 1995;57:33–46.

    Article  CAS  PubMed  Google Scholar 

  29. Pectasides D, Pectasides E, Psyrri A, et al. Treatment issues in clear cell carcinoma of the ovary: a different entity? Oncologist. 2006;11:1089–94.

    Article  PubMed  Google Scholar 

  30. Kawaguchi R, Tsuji Y, Haruta S, et al. Clinicopathologic features of ovarian cancer in patients with ovarian endometrioma. J Obstet Gynaecol Res. 2008;34(5):872–7.

    Article  PubMed  Google Scholar 

  31. Jordan S, Green A, Webb P. Benign epithelial ovarian tumours-cancer precursors or markers for ovarian cancer risk? Cancer Causes Control. 2006;17(5):623–32.

    Article  PubMed  Google Scholar 

  32. Kobayashi H, Ooi H, Yamada Y, et al. Serum CA125 level before the development of ovarian cancer. Int J Gynaecol Obstet. 2007;99(2):95–9.

    Article  CAS  PubMed  Google Scholar 

  33. Horiuchi A, Itoh K, Shimizu M, et al. Toward understanding the natural history of ovarian carcinoma development: a clinicopathological approach. Gynecol Oncol. 2003;88(3):309–17.

    Article  PubMed  Google Scholar 

  34. Okamura H, Katabuchi H, Nitta M, et al. Structural changes and cell properties of human ovarian surface epithelium in ovarian pathophysiology. Microsc Res Tech. 2006;69:469–81.

    Article  PubMed  Google Scholar 

  35. Drapkin R, Crum CP, Hecht JL. Expression of candidate tumor markers in ovarian carcinoma and benign ovary: evidence for a link between epithelial phenotype and neoplasia. Hum Pathol. 2004;35:1014–21.

    Article  CAS  PubMed  Google Scholar 

  36. Deligdisch L, Einstein AJ, Guera D. Ovarian dysplasia in epithelial inclusion cysts. A morphometric approach using neural networks. Cancer. 1995;76:1027–34.

    Article  CAS  PubMed  Google Scholar 

  37. Kurman RJ, Shih IeM. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol. 2008;27(2):151–60.

    PubMed  Google Scholar 

  38. Fleming JS, Beaugié CR, Haviv I, et al. Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses. Mol Cell Endocrinol. 2006;247:4–21.

    Article  CAS  PubMed  Google Scholar 

  39. IeM Shih, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol. 2004;164:1511–8.

    Google Scholar 

  40. Christie M, Oehler MK. Molecular pathology of epithelial ovarian cancer. J Br Menopause Soc. 2006;12(2):57–63.

    Article  PubMed  Google Scholar 

  41. Kobayashi H, Yamada Y, Kanayama S, et al. The role of hepatocyte nuclear factor-1beta in the pathogenesis of clear cell carcinoma of the ovary. Int J Gynecol Cancer. 2009;19(3):471–9.

    PubMed  Google Scholar 

  42. Kobayashi H, Kajiwara H, Kanayama S, et al. Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (Review). Oncol Rep. 2009;22(2):233–40.

    CAS  PubMed  Google Scholar 

  43. Menon U, Talaat A, Jeyarajah AR, et al. Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation. Br J Cancer. 1999;80(10):1644–7.

    Article  CAS  PubMed  Google Scholar 

  44. van der Burg ME, van der Gaast A, et al. What is the role of dose-dense therapy? Int J Gynecol Cancer. 2005;15(Suppl 3):233–40.

    Article  PubMed  Google Scholar 

  45. Anderiesz C, Quinn MA. Screening for ovarian cancer. Med J Aust. 2003;178(12):655–6.

    PubMed  Google Scholar 

  46. van Nagell JR Jr, Gallion HH, Pavlik EJ, et al. Ovarian cancer screening. Cancer. 1995;76(10 Suppl):2086–91.

    Article  PubMed  Google Scholar 

  47. Shimada M, Kigawa J, Ohishi Y, et al. Clinicopathological characteristics of mucinous adenocarcinoma of the ovary. Gynecol Oncol. 2009;113(3):331–4.

    Article  PubMed  Google Scholar 

  48. Hess V, A’Hern R, Nasiri N, et al. Mucinous epithelial ovarian cancer: a separate entity requiring specific treatment. J Clin Oncol. 2004;22(6):1040–4.

    Article  CAS  PubMed  Google Scholar 

  49. Adonakis GL, Paraskevaidis E, Tsiga S, et al. A combined approach for the early detection of ovarian cancer in asymptomatic women. Eur J Obstet Gynecol Reprod Biol. 1996;65(2):221–5.

    Article  CAS  PubMed  Google Scholar 

  50. MacDonald ND, Rosenthal AN, Jacobs IJ. Screening for ovarian cancer. Ann Acad Med Singapore. 1998;27:676–82.

    CAS  PubMed  Google Scholar 

  51. Schwartz PE. Nongenetic screening of ovarian malignancies. Obstet Gynecol Clin North Am. 2001;28(4):637–51.

    Article  CAS  PubMed  Google Scholar 

  52. Jacobs IJ, Skates S, Davies AP, et al. Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study. BMJ. 1996;313(7069):1355–8.

    CAS  PubMed  Google Scholar 

  53. Einhorn N, Bast R, Knapp R, et al. Long-term follow-up of the Stockholm screening study on ovarian cancer. Gynecol Oncol. 2000;79(3):466–70.

    Article  CAS  PubMed  Google Scholar 

  54. Rosenthal A, Jacobs I. Ovarian cancer screening. Semin Oncol. 1998;25(3):315–25.

    CAS  PubMed  Google Scholar 

  55. Jacobs I, Stabile I, Bridges J, et al. Multimodal approach to screening for ovarian cancer. Lancet. 1988;1(8580):268–71.

    Article  CAS  PubMed  Google Scholar 

  56. Yoshida S, Furukawa N, Haruta S, et al. Theoretical model of treatment strategies for clear cell carcinoma of the ovary: focus on perspectives. Cancer Treat Rev. 2009 (Epub ahead of print).

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan

    Hiroshi Kobayashi

Authors
  1. Hiroshi Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroshi Kobayashi.

About this article

Cite this article

Kobayashi, H. Screening, epidemiology, molecular biology, and treatment strategies for endometriosis-associated ovarian cancer. Reprod Med Biol 9, 17–22 (2010). https://doi.org/10.1007/s12522-009-0034-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12522-009-0034-9

Keywords

Search

Navigation